Guselkumab Subcutaneous

DRUG2 trials

Sponsors

Janssen Research & Development, LLC, University of Calgary

Conditions

Colitis, UlcerativeCrohn's Disease of Both Small and Large Intestine

Phase 3

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis

Active, not recruitingNCT06260163

Janssen Research & Development, LLCColitis, Ulcerative

Start: 2024-01-19End: 2027-04-28Updated: 2026-08-28

Unknown Phase

Ultrasound and Proteomics for Guselkumab Response Assessment in Crohn's Disease (UPGRADE).

RecruitingNCT07246460

University of CalgaryCrohn's Disease of Both Small and Large Intestine

Start: 2025-10-31End: 2027-11-30Target: 90Updated: 2025-11-24